Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom 73170, Thailand.
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA.
Viruses. 2023 Apr 30;15(5):1106. doi: 10.3390/v15051106.
The Zika virus (ZIKV), a member of the Flaviviridae family, is considered a major health threat causing multiple cases of microcephaly in newborns and Guillain-Barré syndrome in adults. In this study, we targeted a transient, deep, and hydrophobic pocket of the "super-open" conformation of ZIKV NS2B-NS3 protease to overcome the limitations of the active site pocket. After virtual docking screening of approximately seven million compounds against the novel allosteric site, we selected the top six candidates and assessed them in enzymatic assays. Six candidates inhibited ZIKV NS2B-NS3 protease proteolytic activity at low micromolar concentrations. These six compounds, targeting the selected protease pocket conserved in ZIKV, serve as unique drug candidates and open new opportunities for possible treatment against several flavivirus infections.
寨卡病毒(ZIKV)属于黄病毒科,被认为是一种主要的健康威胁,可导致新生儿小头畸形和成人吉兰-巴雷综合征的大量病例。在这项研究中,我们针对 ZIKV NS2B-NS3 蛋白酶的“超级开放”构象的瞬态、深且疏水口袋,以克服活性口袋的限制。在对新型别构位点进行大约七百万种化合物的虚拟对接筛选后,我们选择了前六名候选物,并在酶测定中对其进行了评估。六种候选物以低微摩尔浓度抑制 ZIKV NS2B-NS3 蛋白酶的蛋白水解活性。这六种针对 ZIKV 中保守的选定蛋白酶口袋的化合物可作为独特的药物候选物,并为可能治疗几种黄病毒感染开辟了新的机会。